Portfolio

Alta Life Sciences participa en el grupo de trabajo de AseBio para impulsar el sector biotech February 25, 2021
binx health Enters into Distribution Agreement for National Launch of the FDA-cleared binx io February 21, 2021
Accure Therapeutics publishes pivotal preclinical efficacy study in epilepsy February 12, 2021
Sanifit Granted Orphan Drug Designation by the FDA for SNF472 for the Treatment of Peripheral Arterial Disease in Patients with End-stage Kidney Disease February 11, 2021
Accure Therapeutics – Webinars on Neuroprotection for Brain Diseases Program February 10, 2021

Passeig de Gràcia, 20 2n 3a
08007 Barcelona
+34 682 300 704
alta@altals.com